Tag: T790M

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to T790M

Tissue May Not Be the Issue When it Comes to Directing Targeted Therapies in Advanced NSCLC

Added to Collection on: 2020-08-24 23:56:15

Tags for this article:

Anatomical pathology
Circulating tumor DNA
Clinical medicine
DNA
Health
Liquid biopsy
Medicine
Neoplasms
Non-small-cell lung carcinoma
Oncology
ROS1
T790M

Click the tags to see associated articles and topics

View Article Details
Low-Level EGFR Variants in NSCLC Detectable by Liquid Biopsy Assays

Added to Collection on: 2020-11-20 17:02:10

Tags for this article:

Clinical medicine
Medicine
Branches of biology
DNA
Tyrosine kinase inhibitors
Anatomical pathology
Circulating tumor DNA
Neoplasms
T790M
Liquid biopsy
Circulating free DNA
Epidermal growth factor receptor
Lei Zhang

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology, Inc. Prevails Before European Patent Office Board of Appeals in Decision ...

Added to Collection on: 2020-12-02 13:30:00

Tags for this article:

Organic compounds
Chemical compounds
Aromatic compounds
Chloroarenes
Quinazolines
Amines
Aromatic amines
Tyrosine kinase receptors
Neratinib
T790M
Gefitinib
Erlotinib
Puma Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing ...

Added to Collection on: 2021-06-30 10:52:30

Tags for this article:

Tyrosine kinase inhibitors
Tyrosine kinase receptors
Lung cancer
T790M
Protein kinase inhibitor
Pharmaceutical industry in China
Epidermal growth factor receptor
Health
Branches of biology
ArriVent Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
Cancer biotech ArriVent Biopharma files for a $100 million IPO - Renaissance Capital

Added to Collection on: 2024-01-06 09:46:39

Tags for this article:

Lung cancer
Quinazolines
Oncogenes
Tyrosine kinase receptors
Tyrosine-kinase inhibitor
Antineoplastic drugs
Epidermal growth factor receptor
Non-small-cell lung cancer
Protein kinase inhibitor
Afatinib
T790M

Click the tags to see associated articles and topics

View Article Details
ArriVent BioPharma Reports Second Quarter 2024 Financial Results - Yahoo Finance

Added to Collection on: 2024-08-14 20:07:06

Tags for this article:

Lung cancer
Oncogenes
Tyrosine kinase receptors
Tyrosine kinase inhibitors
Antineoplastic drugs
T790M
Epidermal growth factor receptor
Non-small-cell lung cancer
Targeted therapy
Protein kinase inhibitor
HER2
ImmunoGen
ARRIVENT BIOPHARMA
ArriVent Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo